Get access to our best features
Get access to our best features
Published 2 months ago

Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments

Summary by Ground News
Cancer immunotherapeutics work by unleashing the power of a patient's immune system to fight cancer. The market, which was valued at US$ 96.40 billion in 2023, is estimated to achieve a remarkable CAGR of 10.02% between the years 2023 and 2030. projections placing its value at approximately US$ 188.11 billion by the end of the decade.

0 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources lean Right
50% Center

To view factuality data please Upgrade to Premium


To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)